The use of high-dose acyclovir in patients with hematological malignancies who develop herpes virus infections: Is it really safe?

• Ismail Sarı,
• Leylagül Kaynar,
• İsmail Koçyiğit,
• Fevzi Altuntas

Affiliations

Ismail Sarı

Pamukkale University, Faculty Of Medicine, Hematology Department, Denizli, Turkey

Leylagül Kaynar

Erciyes University, Faculty Of Medicine, Hematology Department, Kayseri, Turkey

İsmail Koçyiğit

Erciyes University, Faculty Of Medicine, Hematology Department, Kayseri, Turkey

Fevzi Altuntas

Erciyes University, Faculty Of Medicine, Hematology Department, Kayseri, Turkey